Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2023 Earnings Call Transcript November 2, 2023 Ionis Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.03 EPS, expectations were $-1.01. Operator: Good morning, and welcome to Ionis’ Third Quarter 2023 Financial Results Conference Call. As a reminder this call is being recorded. At this time, I would like […]